Condition/disease: Heart Failure; Intervention/treatment: Sodium-Glucose Transporter 2 Inhibitors OR Empagliflozin OR Dapagliflozin OR Ertugliflozin OR Canagliflozin OR Mineralocorticoid Receptor Antagonist OR Eplerenone OR Finerenone OR Spironolactone; Study status: All Studies. This evidence concerns the gene NR3C2 and heart failure.